JP2024536419A5 - - Google Patents
Info
- Publication number
- JP2024536419A5 JP2024536419A5 JP2024521050A JP2024521050A JP2024536419A5 JP 2024536419 A5 JP2024536419 A5 JP 2024536419A5 JP 2024521050 A JP2024521050 A JP 2024521050A JP 2024521050 A JP2024521050 A JP 2024521050A JP 2024536419 A5 JP2024536419 A5 JP 2024536419A5
- Authority
- JP
- Japan
- Prior art keywords
- levothyroxine
- once
- sodium
- kda
- fine particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20210100683A GR1010327B (el) | 2021-10-06 | 2021-10-06 | Παρατεταμενης αποδεσμευσης ενεσιμο φαρμακευτικο σκευασμα λεβοθυροξινης και μεθοδος παρασκευης αυτου |
| GR20210100683 | 2021-10-06 | ||
| GB2119164.8A GB2613656A (en) | 2021-12-13 | 2021-12-13 | Sustained release injectable pharmaceutical formulation of levothyroxine and process for preparation thereof |
| GB2119164.8 | 2021-12-13 | ||
| PCT/EP2022/025463 WO2023057088A1 (en) | 2021-10-06 | 2022-10-06 | Sustained release injectable pharmaceutical formulation of levothyroxine and process for preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536419A JP2024536419A (ja) | 2024-10-04 |
| JP2024536419A5 true JP2024536419A5 (https=) | 2025-10-09 |
Family
ID=83996642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024521050A Pending JP2024536419A (ja) | 2021-10-06 | 2022-10-06 | レボチロキシンの注射可能な徐放性薬学的製剤およびその調製方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250268830A1 (https=) |
| EP (1) | EP4412594A1 (https=) |
| JP (1) | JP2024536419A (https=) |
| KR (1) | KR20240066197A (https=) |
| AU (1) | AU2022360328A1 (https=) |
| CA (1) | CA3234073A1 (https=) |
| CO (1) | CO2024005798A2 (https=) |
| MX (1) | MX2024004141A (https=) |
| WO (1) | WO2023057088A1 (https=) |
| ZA (1) | ZA202403411B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4701631A1 (en) * | 2023-04-28 | 2026-03-04 | Maia Pharmaceuticals, Inc. | Levothyroxine dispersions |
| CN116831994B (zh) * | 2023-06-25 | 2026-03-27 | 湖南赛隆药业(长沙)有限公司 | 一种注射用左甲状腺素钠缓释微球冻干制剂及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1127634A (zh) | 1995-04-06 | 1996-07-31 | 中国科学院成都有机化学研究所 | 一种激素缓释微球注射剂及其制备方法 |
| CN113384537A (zh) * | 2021-04-25 | 2021-09-14 | 苏州大学 | 一种左旋千金藤啶碱缓释微球及其制备方法 |
-
2022
- 2022-10-06 CA CA3234073A patent/CA3234073A1/en active Pending
- 2022-10-06 JP JP2024521050A patent/JP2024536419A/ja active Pending
- 2022-10-06 MX MX2024004141A patent/MX2024004141A/es unknown
- 2022-10-06 AU AU2022360328A patent/AU2022360328A1/en active Pending
- 2022-10-06 KR KR1020247015048A patent/KR20240066197A/ko active Pending
- 2022-10-06 US US18/697,615 patent/US20250268830A1/en active Pending
- 2022-10-06 WO PCT/EP2022/025463 patent/WO2023057088A1/en not_active Ceased
- 2022-10-06 EP EP22797011.8A patent/EP4412594A1/en active Pending
-
2024
- 2024-05-02 ZA ZA2024/03411A patent/ZA202403411B/en unknown
- 2024-05-03 CO CONC2024/0005798A patent/CO2024005798A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102264351B (zh) | 包含水溶性差的药物的聚合胶束组合物的制备方法 | |
| JP2024536419A5 (https=) | ||
| JP6678571B2 (ja) | 高薬物含有ブプレノルフィンマイクロスフェア及びその製造方法 | |
| AU2014389015B2 (en) | Preparation of peptide loaded PLGA microspheres with controlled release characteristics | |
| KR20190064509A (ko) | 안전성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법 | |
| CN108685858B (zh) | 一种注射用普拉克索缓释制剂及其制备方法 | |
| TWI906350B (zh) | 包括氯胺酮的微球調配物、其製造方法及使用於方法中之組合物 | |
| EP4308106A1 (en) | Microsphere formulations comprising naltrexone and methods for making and using the same | |
| AU2022360328A1 (en) | Sustained release injectable pharmaceutical formulation of levothyroxine and process for preparation thereof | |
| US20120149713A1 (en) | Oral films comprising 7-[4-[4-(2,3-dichlorophenyl) piperazin-1-l]butoxy]-3,4-dihydro-1h-quinolin-2-one base or salts or hydrates thereof | |
| US20240216280A1 (en) | Microsphere formulations comprising nalmefene andmethods for making and using the same | |
| KR20230036886A (ko) | 생분해성 고분자를 이용한 서방형 미립구 및 이의 제조방법 | |
| JP2024536879A5 (https=) | ||
| EP4248950A1 (en) | Injectable composition containing caspase inhibitor, and preparation method therefor | |
| WO2004108115A1 (ja) | 微粒子の製造法 | |
| US20230225993A1 (en) | Microsphere formulations comprising ketamine and methods for making and using the same | |
| US20240000772A1 (en) | Microsphere formulations comprising naltrexone and methods for making and using the same | |
| KR20210158232A (ko) | 치매치료를 위한 장기지속형 주사제 | |
| WO2025117624A1 (en) | Microsphere formulations comprising brexpiprazole and methods for making and using the same | |
| CN117731641A (zh) | 一种光热稳定的维生素k1缓释微球的制备方法 | |
| CN111743868B (zh) | 一种包载盐酸阿比多尔的聚合物胶束的冻干制剂及其制备方法 | |
| WO2023133554A2 (en) | Microsphere formulations comprising ketamine and methods for making and using the same | |
| CN121445850A (zh) | 一种药物缓释微球及其制备方法 | |
| EP4658272A1 (en) | Microsphere formulations comprising naltrexone and methods for making and using the same | |
| HK40105344A (zh) | 左旋甲状腺素的缓释可注射药物制剂及其制备方法 |